Table 2:
Adverse events
| Self-M | Conv-T | P-value | |
|---|---|---|---|
| Bleeding all events, n (%) | 58 (37.2) | 103 (39.6) | 0.213 |
| Grade I bleeding, n (%) | 46 (29.5) | 75 (28.8) | 0.413 |
| Grade II bleeding, n (%) | 21 (13.5) | 37 (14.2) | 0.355 |
| Grade III bleeding, n (%) | 3 (1.9) | 17 (6.5) | 0.068 |
| Grade III bleeding, causing disability or death, n (%) | 0 | 12 (4.6) | 0.030 |
| TE all events, n (%) | 17 (10.6) | 40 (15.4) | 0.064 |
| Grade I TE, n (%) | 14 (8.8) | 22 (8.5) | 0.718 |
| Grade II TE, n (%) | 7 (4.4) | 15 (5.8) | 0.332 |
| Grade III TE, n (%) | 1 (0.6) | 13 (5.0) | 0.011 |
| Grade III TE, causing disability or death, n (%) | 1 (0.6) | 13 (5.0) | 0.011 |
TE, thromboembolism; Self-M, patients with anticoagulation self-management; Conv-T, patients with conventional anticoagulation treatment by family physicians.